Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Zaniboni

Showing results (131-140 of 233) with videos related to

Pageof 24
Sort By:
Oncotarget|September 4, 2015
Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: implications for clinical managementMichela Del Prete, Riccardo Giampieri, Fotios Loupakis, et al.
Palliative & Supportive Care|June 22, 2016
Parents with cancer: Searching for the right balance between telling the truth and protecting childrenFausto Meriggi, Federica Andreis, Nadia Liborio, et al.
Med (New York, N.Y.)|June 29, 2026
Advanced cholangiocarcinoma in 2025: Therapeutic sequencing and global implementationFausto Petrelli, Chiara Pesenti, Fulvia Milena Cribiù, et al.
Medicina (Kaunas, Lithuania)|February 24, 2024
Different Chemotherapy Regimens and Pathologic Complete Response in Triple-Negative Breast Cancer: An Updated Network Meta-Analysis of Phase 3 TrialsFausto Petrelli, Gianluca Tomasello, Maria Chiara Parati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2007
Nuclear factor-kB tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapyMario Scartozzi, Italo Bearzi, Chiara Pierantoni, et al.
Tumori|December 16, 2006
Capecitabine and mitomycin C may be an effective treatment option for third-line chemotherapy in advanced colorectal cancerMario Scartozzi, Alfredo Falcone, Francesca Pucci, et al.
European Journal of Cancer (Oxford, England : 1990)|December 11, 2008
Incidence and clinical implications of venous thromboembolism in advanced colorectal cancer patients: the 'GISCAD-alternating schedule' study findingsMario Mandalà, Sandro Barni, Irene Floriani, et al.
Cancer|October 25, 2011
Final results of a phase 2A study for the treatment of metastatic neuroendocrine tumors with a fixed activity of 90Y-DOTA-D-Phe1-Tyr3 octreotideGiordano Savelli, Francesco Bertagna, Fabio Franco, et al.
Critical Reviews in Oncology/Hematology|May 21, 2010
The impact of anemia on quality of life and hospitalisation in elderly cancer patients undergoing chemotherapyLaura Doni, Alessandra Perin, Luigi Manzione, et al.
American Journal of Clinical Oncology|March 11, 2026
Adjuvant Chemotherapy After Curative Intent Resection of Ampullary Cancer (ADAPTA): Study Protocol for a Pan-European Prospective Multicenter Double Single Arm TrialBas A Uijterwijk, Daniel H L Lemmers, Dorine S Klei, et al.
Pageof 24

Showing results (131-140 of 233) with videos related to

Sort By:
Pageof 24
Oncotarget|September 4, 2015
Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: implications for clinical managementMichela Del Prete, Riccardo Giampieri, Fotios Loupakis, et al.
Palliative & Supportive Care|June 22, 2016
Parents with cancer: Searching for the right balance between telling the truth and protecting childrenFausto Meriggi, Federica Andreis, Nadia Liborio, et al.
Med (New York, N.Y.)|June 29, 2026
Advanced cholangiocarcinoma in 2025: Therapeutic sequencing and global implementationFausto Petrelli, Chiara Pesenti, Fulvia Milena Cribiù, et al.
Medicina (Kaunas, Lithuania)|February 24, 2024
Different Chemotherapy Regimens and Pathologic Complete Response in Triple-Negative Breast Cancer: An Updated Network Meta-Analysis of Phase 3 TrialsFausto Petrelli, Gianluca Tomasello, Maria Chiara Parati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2007
Nuclear factor-kB tumor expression predicts response and survival in irinotecan-refractory metastatic colorectal cancer treated with cetuximab-irinotecan therapyMario Scartozzi, Italo Bearzi, Chiara Pierantoni, et al.
Tumori|December 16, 2006
Capecitabine and mitomycin C may be an effective treatment option for third-line chemotherapy in advanced colorectal cancerMario Scartozzi, Alfredo Falcone, Francesca Pucci, et al.
European Journal of Cancer (Oxford, England : 1990)|December 11, 2008
Incidence and clinical implications of venous thromboembolism in advanced colorectal cancer patients: the 'GISCAD-alternating schedule' study findingsMario Mandalà, Sandro Barni, Irene Floriani, et al.
Cancer|October 25, 2011
Final results of a phase 2A study for the treatment of metastatic neuroendocrine tumors with a fixed activity of 90Y-DOTA-D-Phe1-Tyr3 octreotideGiordano Savelli, Francesco Bertagna, Fabio Franco, et al.
Critical Reviews in Oncology/Hematology|May 21, 2010
The impact of anemia on quality of life and hospitalisation in elderly cancer patients undergoing chemotherapyLaura Doni, Alessandra Perin, Luigi Manzione, et al.
American Journal of Clinical Oncology|March 11, 2026
Adjuvant Chemotherapy After Curative Intent Resection of Ampullary Cancer (ADAPTA): Study Protocol for a Pan-European Prospective Multicenter Double Single Arm TrialBas A Uijterwijk, Daniel H L Lemmers, Dorine S Klei, et al.
Pageof 24